Probiotics Dietary Supplements Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others), By End-use (Infants, Children, Adults, Geriatric), By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others), By Region & Competition, 2021-2031F

May 2026 | 182 pages | ID: P11860805979EN
TechSci Research

Abstracts

The Global Probiotics Dietary Supplements Market is projected to expand significantly, growing from USD 9.19 Billion in 2025 to USD 17.21 Billion by 2031, at an impressive CAGR of 11.02%. Probiotics dietary supplements are carefully crafted formulations containing living microorganisms, primarily bacteria and yeasts, designed to deliver specific health benefits by maintaining or restoring the gut microbiome's natural balance. This market growth is fundamentally propelled by a worldwide focus on preventive healthcare and consumers' increasing understanding of the crucial connection between digestive well-being and overall immune function. These foundational drivers represent a significant shift in how individuals approach long-term wellness and disease prevention through their diets, rather than being mere transient consumption trends. However, the sector faces substantial challenges from the stringent regulatory environment governing health claims and product stability. This necessitates considerable investment from manufacturers in scientific validation to ensure both strain viability and compliance with labeling regulations. Such regulatory complexities can impede market entry and slow the pace of product innovation for newer brands. In 2024, the Americas region notably captured 34% of the global probiotic supplements retail market, according to the International Probiotics Association, underscoring the intense competition and high standards required for market penetration in established areas.

Market Driver

Consumer awareness regarding the intricate link between gut health and systemic well-being is profoundly transforming the market, as individuals increasingly acknowledge the microbiome's influence on broader physiological systems, particularly in areas like weight management and metabolic function. This trend is further amplified by the growing use of GLP-1 medications, with probiotics being adopted to alleviate gastrointestinal side effects and enhance overall digestive comfort. A June 2025 'Consumer Perception Study' by Kerry Group revealed that 91% of GLP-1 medication users would recommend a specific BC30 probiotic formulation to others on similar treatment regimens, indicating a discerning consumer base that perceives probiotics as essential complements to complex medical treatments and comprehensive wellness strategies, beyond simple digestive aids. A global shift towards proactive and preventive healthcare is simultaneously driving consistent demand for daily supplementation. Consumers are increasingly prioritizing long-term wellness approaches over reactive treatments, leading to sustained engagement with specialized categories. The Council for Responsible Nutrition's February 2025 '2024 Consumer Survey on Dietary Supplements' reported that 75% of Americans continued using dietary supplements, with probiotics remaining a top specialty choice alongside sleep aids. This forward-thinking mindset is particularly strong in emerging markets where rising disposable incomes coincide with improved health literacy. Highlighting this regional vitality, the Asia Pacific region led in value sales in 2024, according to the International Probiotics Association, and is projected to maintain a 9.2% growth rate through 2028, surpassing other established territories.

Market Challenge

The stringent regulatory framework governing health claims and product stability poses a persistent impediment to the vigorous expansion of the global probiotics dietary supplements market. Unlike conventional dietary formulations, probiotics incorporate live microorganisms that must maintain viability from production through to consumption, demanding extensive and costly stability testing. Regulatory bodies enforce rigorous standards for health claims, compelling manufacturers to invest significant capital in scientific validation and clinical trials to ensure adherence to labeling requirements. This substantial financial burden forces companies to reallocate resources away from market expansion and consumer education, directly diminishing the speed at which new products can be introduced and stifling the overall momentum of the industry. Consequently, these regulatory complexities establish high barriers to entry that disproportionately impact smaller or emerging brands, which frequently lack the necessary financial resources to navigate such demands. This dynamic creates a market environment largely dominated by established players and restricts the influx of diverse, innovative solutions that could otherwise address evolving consumer health needs. Although the global probiotic supplements market was projected to grow at a rate of 7.5% over the next four years as per the International Probiotics Association in 2024, this positive growth trajectory is invariably tempered by these regulatory hurdles, which cap the potential for more rapid product diversification and broader market penetration.

Market Trends

A significant shift is occurring in the market with the emergence of psychobiotics, as consumers increasingly leverage the gut-brain axis to support mental well-being and enhance stress resilience. This trend extends beyond conventional digestive health applications, positioning probiotics as functional tools for mood regulation and improved sleep quality. Manufacturers are responding by commercializing specific strains that have been clinically demonstrated to modulate neurotransmitter production, thereby catering to a demographic that regards mental health as a fundamental aspect of physical vitality. According to the Council for Responsible Nutrition's February 2025 '2024 Consumer Survey on Dietary Supplements', 19% of consumers cited mental health and 22% cited sleep health as key reasons for taking supplements, indicating a considerable broadening of the category's appeal beyond solely gut-focused issues. Simultaneously, the incorporation of probiotics into sports nutrition is redefining the active lifestyle segment. Brands are developing "protein-plus" solutions where probiotics are added to enhance nutrient absorption, reduce exercise-induced inflammation, and support immune recovery in athletes. This integration allows probiotics to penetrate the mainstream active nutrition market, transitioning from standalone pills to functional powders and beverages. This evolution is underpinned by the surging demand for protein-enriched diets among general consumers, creating fertile ground for synbiotic fortifications. FrieslandCampina Ingredients' January 2025 'Nutritional Trends 2025' report noted that 71% of global consumers actively prioritize protein in their diets, a substantial increase from 59% in 2022, signaling a massive opportunity for probiotic strains that can be co-formulated into high-protein applications.

Key Market Players

• Vitakem Nutraceutical Inc
• Lesaffre International Corp
• DuPont de Nemours Inc
• H&H Group PLC
• Amway Corp
• Abbott Laboratories Inc
• Bayer AG
• Pfizer Inc.
• GSK PLC
• BASF SE

Report Scope

In this report, the Global Probiotics Dietary Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Probiotics Dietary Supplements Market, By Form
• Chewables & Gummies
• Capsules
• Powders
• Tablets & Softgels
• Others
• Probiotics Dietary Supplements Market, By End-use
• Infants
• Children
• Adults
• Geriatric
• Probiotics Dietary Supplements Market, By Applications
• Sports Fitness
• Energy & Weight Management
• General Health
• Bone & Joint Health
• Gastrointestinal Health
• Immunity
• Cardiac Health
• Diabetes
• Anti-cancer
• Skin/Hair/Nails
• Brain/Mental Health
• Others
• Probiotics Dietary Supplements Market, By Region
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Probiotics Dietary Supplements Market.

Available Customizations:

Global Probiotics Dietary Supplements Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL PROBIOTICS DIETARY SUPPLEMENTS MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
  5.2.2. By End-use (Infants, Children, Adults, Geriatric)
  5.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
  5.2.4. By Region
  5.2.5. By Company (2025)
5.3. Market Map

6. NORTH AMERICA PROBIOTICS DIETARY SUPPLEMENTS MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Form
  6.2.2. By End-use
  6.2.3. By Applications
  6.2.4. By Country
6.3. North America: Country Analysis
  6.3.1. United States Probiotics Dietary Supplements Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Form
      6.3.1.2.2. By End-use
      6.3.1.2.3. By Applications
  6.3.2. Canada Probiotics Dietary Supplements Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Form
      6.3.2.2.2. By End-use
      6.3.2.2.3. By Applications
  6.3.3. Mexico Probiotics Dietary Supplements Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Form
      6.3.3.2.2. By End-use
      6.3.3.2.3. By Applications

7. EUROPE PROBIOTICS DIETARY SUPPLEMENTS MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Form
  7.2.2. By End-use
  7.2.3. By Applications
  7.2.4. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany Probiotics Dietary Supplements Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Form
      7.3.1.2.2. By End-use
      7.3.1.2.3. By Applications
  7.3.2. France Probiotics Dietary Supplements Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Form
      7.3.2.2.2. By End-use
      7.3.2.2.3. By Applications
  7.3.3. United Kingdom Probiotics Dietary Supplements Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Form
      7.3.3.2.2. By End-use
      7.3.3.2.3. By Applications
  7.3.4. Italy Probiotics Dietary Supplements Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Form
      7.3.4.2.2. By End-use
      7.3.4.2.3. By Applications
  7.3.5. Spain Probiotics Dietary Supplements Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Form
      7.3.5.2.2. By End-use
      7.3.5.2.3. By Applications

8. ASIA PACIFIC PROBIOTICS DIETARY SUPPLEMENTS MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Form
  8.2.2. By End-use
  8.2.3. By Applications
  8.2.4. By Country
8.3. Asia Pacific: Country Analysis
  8.3.1. China Probiotics Dietary Supplements Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Form
      8.3.1.2.2. By End-use
      8.3.1.2.3. By Applications
  8.3.2. India Probiotics Dietary Supplements Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Form
      8.3.2.2.2. By End-use
      8.3.2.2.3. By Applications
  8.3.3. Japan Probiotics Dietary Supplements Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Form
      8.3.3.2.2. By End-use
      8.3.3.2.3. By Applications
  8.3.4. South Korea Probiotics Dietary Supplements Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Form
      8.3.4.2.2. By End-use
      8.3.4.2.3. By Applications
  8.3.5. Australia Probiotics Dietary Supplements Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Form
      8.3.5.2.2. By End-use
      8.3.5.2.3. By Applications

9. MIDDLE EAST & AFRICA PROBIOTICS DIETARY SUPPLEMENTS MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Form
  9.2.2. By End-use
  9.2.3. By Applications
  9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
  9.3.1. Saudi Arabia Probiotics Dietary Supplements Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Form
      9.3.1.2.2. By End-use
      9.3.1.2.3. By Applications
  9.3.2. UAE Probiotics Dietary Supplements Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Form
      9.3.2.2.2. By End-use
      9.3.2.2.3. By Applications
  9.3.3. South Africa Probiotics Dietary Supplements Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Form
      9.3.3.2.2. By End-use
      9.3.3.2.3. By Applications

10. SOUTH AMERICA PROBIOTICS DIETARY SUPPLEMENTS MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Form
  10.2.2. By End-use
  10.2.3. By Applications
  10.2.4. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Probiotics Dietary Supplements Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Form
      10.3.1.2.2. By End-use
      10.3.1.2.3. By Applications
  10.3.2. Colombia Probiotics Dietary Supplements Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Form
      10.3.2.2.2. By End-use
      10.3.2.2.3. By Applications
  10.3.3. Argentina Probiotics Dietary Supplements Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Form
      10.3.3.2.2. By End-use
      10.3.3.2.3. By Applications

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. GLOBAL PROBIOTICS DIETARY SUPPLEMENTS MARKET: SWOT ANALYSIS

14. PORTER'S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. Vitakem Nutraceutical Inc
  15.1.1. Business Overview
  15.1.2. Products & Services
  15.1.3. Recent Developments
  15.1.4. Key Personnel
  15.1.5. SWOT Analysis
15.2. Lesaffre International Corp
15.3. DuPont de Nemours Inc
15.4. H&H Group PLC
15.5. Amway Corp
15.6. Abbott Laboratories Inc
15.7. Bayer AG
15.8. Pfizer Inc.
15.9. GSK PLC
15.10. BASF SE

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER